Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Biochemical and Biophysical Research Communications|July 26, 2005
Demonstration of an in vivo generated sub-picomolar affinity fully human monoclonal antibody to interleukin-8Palaniswami Rathanaswami, Shelly Roalstad, Lorin Roskos, et al.
Contemporary Clinical Trials|June 6, 2022
Development of a risk assessment and risk management tool for an academic research organizationJohn M VanBuren, Shelly Roalstad, Marie T Kay, et al.
Journal of the Neurological Sciences|March 23, 2016
Gut microbiota composition and relapse risk in pediatric MS: A pilot studyHelen Tremlett, Douglas W Fadrosh, Ali A Faruqi, et al.
European Journal of Neurology|May 14, 2016
Gut microbiota in early pediatric multiple sclerosis: a case-control studyHelen Tremlett, Douglas W Fadrosh, Ali A Faruqi, et al.
BMC Neurology|September 23, 2016
Associations between the gut microbiota and host immune markers in pediatric multiple sclerosis and controlsHelen Tremlett, Douglas W Fadrosh, Ali A Faruqi, et al.
Journal of Child Neurology|October 2, 2014
The US Network of Pediatric Multiple Sclerosis Centers: Development, Progress, and Next StepsT Charles Casper, John W Rose, Shelly Roalstad, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 24, 2023
Characteristics of pediatric patients with multiple sclerosis and related disorders infected with SARS-CoV-2Teri Schreiner, Molly Wilson-Murphy, Jan Mendelt-Tillema, et al.
Neurology|December 9, 2021
Association Between Time Spent Outdoors and Risk of Multiple SclerosisPrince Sebastian, Nicolas Cherbuin, Lisa F Barcellos, et al.
Pageof 3